Back to Agenda
Round Table Discussion: Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned?
Session Chair(s)
Mary Murray, MBA, MS
Family Caregiver, Independent Consultant, United States
Join DIA Patient Engagement Community for a round table discussion tied to session #310 SL Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned? scheduled for Wednesday, June 30 3-4 PM EDT. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.
Speaker(s)
Theresa Mullin, PHD
Associate Center Director - CDER, FDA, United States
François Houyez
Treatment Information and Access Director, Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS), France
Lembit Rago, DrMed, MD, PHD
Secretary General, Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Juan Garcia-Burgos, MD, PHD
Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands
Talia Lacroix, MPA
Senior Policy Analyst, Health Product and Food Branch, Health Canada, Canada
Have an account?